230 related articles for article (PubMed ID: 35248713)
1. Pancreatic neuroendocrine neoplasms: Updates on genomic changes in inherited tumour syndromes and sporadic tumours based on WHO classification.
Ishida H; Lam AK
Crit Rev Oncol Hematol; 2022 Apr; 172():103648. PubMed ID: 35248713
[TBL] [Abstract][Full Text] [Related]
2. Neoplasms of the Neuroendocrine Pancreas: An Update in the Classification, Definition, and Molecular Genetic Advances.
Guilmette JM; Nosé V
Adv Anat Pathol; 2019 Jan; 26(1):13-30. PubMed ID: 29912000
[TBL] [Abstract][Full Text] [Related]
3. Genetics of Pancreatic Neuroendocrine Tumors.
Mohindroo C; McAllister F; De Jesus-Acosta A
Hematol Oncol Clin North Am; 2022 Oct; 36(5):1033-1051. PubMed ID: 36154786
[TBL] [Abstract][Full Text] [Related]
4. [Inherited tumor syndromes of gastroenteropancreatic and thoracic neuroendocrine neoplasms].
Couvelard A; Scoazec JY
Ann Pathol; 2020 Apr; 40(2):120-133. PubMed ID: 32035641
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic Neuroendocrine Neoplasms: 2020 Update on Pathologic and Imaging Findings and Classification.
Khanna L; Prasad SR; Sunnapwar A; Kondapaneni S; Dasyam A; Tammisetti VS; Salman U; Nazarullah A; Katabathina VS
Radiographics; 2020; 40(5):1240-1262. PubMed ID: 32795239
[TBL] [Abstract][Full Text] [Related]
6. The evolving (epi)genetic landscape of pancreatic neuroendocrine tumours.
Pipinikas CP; Berner AM; Sposito T; Thirlwell C
Endocr Relat Cancer; 2019 Aug; 26(9):R519-R544. PubMed ID: 31252410
[TBL] [Abstract][Full Text] [Related]
7. Molecular profile of pancreatic neuroendocrine neoplasms (PanNENs): Opportunities for personalized therapies.
Arakelyan J; Zohrabyan D; Philip PA
Cancer; 2021 Feb; 127(3):345-353. PubMed ID: 33270905
[TBL] [Abstract][Full Text] [Related]
8. Genomic characterization of a well-differentiated grade 3 pancreatic neuroendocrine tumor.
Williamson LM; Steel M; Grewal JK; Thibodeau ML; Zhao EY; Loree JM; Yang KC; Gorski SM; Mungall AJ; Mungall KL; Moore RA; Marra MA; Laskin J; Renouf DJ; Schaeffer DF; Jones SJM
Cold Spring Harb Mol Case Stud; 2019 Jun; 5(3):. PubMed ID: 31160355
[TBL] [Abstract][Full Text] [Related]
9. Indications for genetic study in gastro-entero-pancreatic and thoracic neuroendocrine tumors.
Araujo-Castro M
Endocrinol Diabetes Nutr (Engl Ed); 2023 Mar; 70 Suppl 1():63-73. PubMed ID: 36396595
[TBL] [Abstract][Full Text] [Related]
10. Genetic disorders and insulinoma/glucagonoma.
Marini F; Giusti F; Brandi ML
Endocr Relat Cancer; 2024 May; 31(5):. PubMed ID: 38552306
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic neuroendocrine carcinomas reveal a closer relationship to ductal adenocarcinomas than to neuroendocrine tumors G3.
Konukiewitz B; Jesinghaus M; Steiger K; Schlitter AM; Kasajima A; Sipos B; Zamboni G; Weichert W; Pfarr N; Klöppel G
Hum Pathol; 2018 Jul; 77():70-79. PubMed ID: 29596894
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic neuroendocrine neoplasms: Clinicopathological features and pathological staging.
Lam AK; Ishida H
Histol Histopathol; 2021 Apr; 36(4):367-382. PubMed ID: 33305819
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies.
Ruggeri RM; Benevento E; De Cicco F; Fazzalari B; Guadagno E; Hasballa I; Tarsitano MG; Isidori AM; Colao A; Faggiano A;
J Endocrinol Invest; 2023 Feb; 46(2):213-234. PubMed ID: 36038743
[TBL] [Abstract][Full Text] [Related]
14. [Genetics of neuroendocrine tumours, hereditary tumour syndromes].
Igaz P
Orv Hetil; 2013 Sep; 154(39):1541-8. PubMed ID: 24058099
[TBL] [Abstract][Full Text] [Related]
15. Integrated Genomic and Clinicopathologic Approach Distinguishes Pancreatic Grade 3 Neuroendocrine Tumor From Neuroendocrine Carcinoma and Identifies a Subset With Molecular Overlap.
Umetsu SE; Kakar S; Basturk O; Kim GE; Chatterjee D; Wen KW; Hale G; Shafizadeh N; Cho SJ; Whitman J; Gill RM; Jones KD; Navale P; Bergsland E; Klimstra D; Joseph NM
Mod Pathol; 2023 Mar; 36(3):100065. PubMed ID: 36788102
[TBL] [Abstract][Full Text] [Related]
16. A Clinicopathologic and Molecular Update of Pancreatic Neuroendocrine Neoplasms With a Focus on the New World Health Organization Classification.
Fang JM; Shi J
Arch Pathol Lab Med; 2019 Nov; 143(11):1317-1326. PubMed ID: 31509453
[TBL] [Abstract][Full Text] [Related]
17. An update on genetically engineered mouse models of pancreatic neuroendocrine neoplasms.
Gaspar TB; Lopes JM; Soares P; Vinagre J
Endocr Relat Cancer; 2022 Dec; 29(12):R191-R208. PubMed ID: 36197786
[TBL] [Abstract][Full Text] [Related]
18. Somatic and germline mutations in NETs: Implications for their diagnosis and management.
Minnetti M; Grossman A
Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):115-27. PubMed ID: 26971848
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
Toumpanakis CG; Caplin ME
Am J Gastroenterol; 2008 Mar; 103(3):729-32. PubMed ID: 18341492
[TBL] [Abstract][Full Text] [Related]
20. The genetics of neuroendocrine tumors.
Öberg K
Semin Oncol; 2013 Feb; 40(1):37-44. PubMed ID: 23391111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
